We feel that there has to be balance in any investment portfolio. We will be providing a general as well as biotech investment portfolio. In order to participate with MindReader stock pick you can connect and subscribe to MindReader.

General Portfolio

We offer a diversified portfolio of companies that we believe have strong potential and are already well-researched. To keep things straightforward, we will list the portfolio names without providing detailed fundamental or technical commentary. Subscribers will be notified promptly whenever we make additions, sales, or other changes to the General Portfolio. All stocks featured here are part of Dr. Forsyth’s active personal portfolio, reflecting his own market positions.

We maintain an extensive list of biotechnology stocks spanning a wide range of risk profiles. It is important to recognize that biotechnology is an industry shaped by regulatory pathways, policy shifts, and global market dynamics. With elevated risk comes the potential for significant reward. While the sector has historically consumed substantial capital, Dr. Forsyth believes that biotechnology has now reached a critical inflection point, with market conditions fundamentally shifting in favor of innovation and scientific progress. All stocks discussed are currently held in Dr. Forsyth’s portfolio and will be updated regularly. Dr. Gupta will gradually review individual companies and explain the underlying science and research driving each opportunity. MindReader’s disciplined approach combining rigorous scientific evaluation with thoughtful market timing has been formalized into the MindReaderBio.tech analytical framework. Dr. Forsyth maintains positions in all listed companies but may revise his views as conditions evolve in this inherently volatile sector. To support transparency, we are developing a notification system to better communicate changes in outlook to our subscribers. Any stock references represent MindReader Bio’s research and analysis and may not be suitable for every investor. Readers should conduct their own due diligence and carefully assess their individual risk tolerance before initiating any position.